Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Fickert

Showing results (141-150 of 163) with videos related to

Pageof 17
Sort By:
Gastroenterology|October 18, 2011
Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injuryTarek Moustafa, Peter Fickert, Christoph Magnes, et al.
Respiratory Medicine|September 17, 2022
Pulmonary vascular disease and exercise hemodynamics in chronic liver diseasePhilipp Douschan, Gabor Kovacs, Teresa Sassmann, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 25, 2021
Secondary (iso)BAs cooperate with endogenous ligands to activate FXR under physiological and pathological conditionsAlex Zaufel, Sandra M W van de Wiel, Lu Yin, et al.
Journal of Hepatology|February 25, 2014
Characterization of animal models for primary sclerosing cholangitis (PSC)Peter Fickert, Marion J Pollheimer, Ulrich Beuers, et al.
Journal of Hepatology|March 1, 2017
NorUrsodeoxycholic acid ameliorates cholemic nephropathy in bile duct ligated miceElisabeth Krones, Kathrin Eller, Marion J Pollheimer, et al.
Plos One|October 29, 2015
Lactobacillus casei Shirota Supplementation Does Not Restore Gut Microbiota Composition and Gut Barrier in Metabolic Syndrome: A Randomized Pilot StudyVanessa Stadlbauer, Bettina Leber, Sandra Lemesch, et al.
Journal of Hepatology|December 3, 2014
24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasisMartina Sombetzki, Claudia D Fuchs, Peter Fickert, et al.
Gastroenterology|March 3, 2010
Signal transducer and activator of transcription 3 protects from liver injury and fibrosis in a mouse model of sclerosing cholangitisMarkus Mair, Gernot Zollner, Doris Schneller, et al.
The American Journal of Pathology|November 14, 2009
Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblastsPeter Fickert, Andrea Fuchsbichler, Tarek Moustafa, et al.
Hepatology (Baltimore, Md.)|July 2, 2013
Bile acids trigger cholemic nephropathy in common bile-duct-ligated micePeter Fickert, Elisabeth Krones, Marion J Pollheimer, et al.
Pageof 17

Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
Gastroenterology|October 18, 2011
Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injuryTarek Moustafa, Peter Fickert, Christoph Magnes, et al.
Respiratory Medicine|September 17, 2022
Pulmonary vascular disease and exercise hemodynamics in chronic liver diseasePhilipp Douschan, Gabor Kovacs, Teresa Sassmann, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 25, 2021
Secondary (iso)BAs cooperate with endogenous ligands to activate FXR under physiological and pathological conditionsAlex Zaufel, Sandra M W van de Wiel, Lu Yin, et al.
Journal of Hepatology|February 25, 2014
Characterization of animal models for primary sclerosing cholangitis (PSC)Peter Fickert, Marion J Pollheimer, Ulrich Beuers, et al.
Journal of Hepatology|March 1, 2017
NorUrsodeoxycholic acid ameliorates cholemic nephropathy in bile duct ligated miceElisabeth Krones, Kathrin Eller, Marion J Pollheimer, et al.
Plos One|October 29, 2015
Lactobacillus casei Shirota Supplementation Does Not Restore Gut Microbiota Composition and Gut Barrier in Metabolic Syndrome: A Randomized Pilot StudyVanessa Stadlbauer, Bettina Leber, Sandra Lemesch, et al.
Journal of Hepatology|December 3, 2014
24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasisMartina Sombetzki, Claudia D Fuchs, Peter Fickert, et al.
Gastroenterology|March 3, 2010
Signal transducer and activator of transcription 3 protects from liver injury and fibrosis in a mouse model of sclerosing cholangitisMarkus Mair, Gernot Zollner, Doris Schneller, et al.
The American Journal of Pathology|November 14, 2009
Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblastsPeter Fickert, Andrea Fuchsbichler, Tarek Moustafa, et al.
Hepatology (Baltimore, Md.)|July 2, 2013
Bile acids trigger cholemic nephropathy in common bile-duct-ligated micePeter Fickert, Elisabeth Krones, Marion J Pollheimer, et al.
Pageof 17